Fig. 2From: Trends in access to anti‐malarial treatment in the formal private sector in Uganda: an assessment of availability and affordability of first‐line anti‐malarials and diagnostics between 2007 and 2018Trends in prices (in USD) and affordability of A/L and mRDTs in private facilities in UgandaBack to article page